Literature DB >> 17021634

Translation research in prostate cancer.

Danil V Makarov, Alan W Partin.   

Abstract

Entities:  

Year:  2006        PMID: 17021634      PMCID: PMC1578537     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


× No keyword cloud information.
  8 in total

1.  Improved biomarkers for prostate cancer: a definite need.

Authors:  H Ballentine Carter; William B Isaacs
Journal:  J Natl Cancer Inst       Date:  2004-06-02       Impact factor: 13.506

2.  Prostate cancers in men with low PSA levels--must we find them?

Authors:  H Ballentine Carter
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

3.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

4.  Immune response as a biomarker for cancer detection and a lot more.

Authors:  Olivera J Finn
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

5.  Autoantibody signatures in prostate cancer.

Authors:  Xiaoju Wang; Jianjun Yu; Arun Sreekumar; Sooryanarayana Varambally; Ronglai Shen; Donald Giacherio; Rohit Mehra; James E Montie; Kenneth J Pienta; Martin G Sanda; Philip W Kantoff; Mark A Rubin; John T Wei; Debashis Ghosh; Arul M Chinnaiyan
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

6.  Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Authors:  Daniel P Petrylak; Catherine M Tangen; Maha H A Hussain; Primo N Lara; Jeffrey A Jones; Mary Ellen Taplin; Patrick A Burch; Donna Berry; Carol Moinpour; Manish Kohli; Mitchell C Benson; Eric J Small; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

7.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Authors:  Ian F Tannock; Ronald de Wit; William R Berry; Jozsef Horti; Anna Pluzanska; Kim N Chi; Stephane Oudard; Christine Théodore; Nicholas D James; Ingela Turesson; Mark A Rosenthal; Mario A Eisenberger
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

8.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.